NCT04609592 - Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

July 31, 2026

Study Completion Date

September 30, 2027

Conditions

Gastroenteropancreatic Neuroendocrine Tumor

Interventions

DRUG

Lutathera

4 administrations of 7.4 gigabecquerel (GBq) (200 mCi) 177Lu Dotatate +/ 10% at the date and time of infusion, accumulative dose of 29.6 GBq (800 mCi). T

DRUG

Gallium 68 Dotatate

Standard of care, 2 Megabecquerel (MBq)/kg (0.054 mCi/kg) up to 200 MBq (5.4 mCi)

PROCEDURE

Computed Tomography (CT)

Medical Imaging

PROCEDURE

Magnetic Resonance Imaging (MRI)

Medical Imaging

PROCEDURE

PET/CT

Medical Imaging

Trial Locations (1)

95304

RECRUITING

Stanford Cancer Institute Palo Alto, Stanford